Inactive Instrument
Pressure BioSciences, Inc. Stock Other OTC
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 143K 126K 116K 109K 204K 13.58M 207K 1.39M 539K 6.66M 538K 527K 23.16M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.16M 18.58M 17.39M 32.58M 2.17B 33.13M 223M 86.34M 1.07B 86.15M 84.29M 3.71B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 51.56K | ||
| +1.15% | -0.69% | +17.28% | -10.47% | 172B | ||
| +0.06% | -3.33% | -21.73% | +23.20% | 143B | ||
| +0.44% | -1.31% | -8.85% | -24.86% | 126B | ||
| +2.86% | -2.81% | -55.45% | -15.51% | 65.89B | ||
| +1.25% | -1.84% | +15.44% | -3.75% | 49.45B | ||
| +0.06% | -1.26% | -25.33% | -31.86% | 44.05B | ||
| +0.14% | -1.30% | +9.08% | +6.07% | 35.72B | ||
| -0.29% | -0.93% | +4.19% | +37.47% | 35.18B | ||
| +5.08% | +0.77% | -10.46% | -20.17% | 27.58B | ||
| Average | +0.91% | -2.49% | -8.43% | -4.43% | 77.68B | |
| Weighted average by Cap. | +0.89% | -2.43% | -7.24% | -4.67% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.52M 1.4M 1.31M 2.46M 164M 2.5M 16.81M 6.51M 80.38M 6.49M 6.35M 279M | 1.98M 1.74M 1.6M 1.5M 2.81M 187M 2.86M 19.22M 7.44M 91.92M 7.42M 7.26M 319M |
| Net income | -16.08M -14.12M -13.01M -12.18M -22.83M -1.52B -23.21M -156M -60.49M -747M -60.35M -59.05M -2.6B | -29.31M -25.75M -23.73M -22.21M -41.62M -2.78B -42.32M -285M -110M -1.36B -110M -108M -4.74B |
| Net Debt | 20.53M 18.03M 16.62M 15.55M 29.14M 1.94B 29.63M 200M 77.23M 954M 77.05M 75.4M 3.32B | 22.8M 20.03M 18.46M 17.28M 32.38M 2.16B 32.92M 222M 85.8M 1.06B 85.61M 83.77M 3.68B |
Employees
-
















